In our studies, overexpression of SphK1 in follicular ML-1 and FTC-133 thyroid cancer cells resulted in a decreased proliferation, compared with mock-transduced cells or cells transduced with the inactive G82D mutant of SphK1 [33]. This evidence concerns the gene SPHK1 and thyroid cancer.